4//SEC Filing
Hoffmann Rolf K 4
Accession 0000904454-18-000329
CIK 0001178711other
Filed
May 1, 8:00 PM ET
Accepted
May 2, 4:29 PM ET
Size
8.2 KB
Accession
0000904454-18-000329
Insider Transaction Report
Form 4
Hoffmann Rolf K
Director
Transactions
- Award
Common Stock
2018-04-30+15,000→ 18,500 total - Award
Stock Option (right to buy)
2018-04-30+10,000→ 10,000 totalExercise: $10.70Exp: 2028-04-30→ Common Stock (10,000 underlying)
Footnotes (3)
- [F1]Represents restricted stock units granted to the Reporting Person under the Paratek Pharmaceuticals, Inc. 2015 Equity Incentive Plan, pursuant to the Paratek Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, effective January 1, 2018. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock. The restricted stock units shall vest as to 1/3 of the shares subject to the restricted stock units on April 30, 2019, and on the same calendar date of each successive year thereafter until fully vested, subject to the Reporting Person's continued service with the Issuer through each vesting date.
- [F2]The exercise price is equal to the closing sales price per share of Common Stock as reported on The Nasdaq Global Market on the date of grant.
- [F3]The stock option was granted to the Reporting Person under the Paratek Pharmaceuticals, Inc. 2015 Equity Incentive Plan, pursuant to the Paratek Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, effective January 1, 2018. The stock option shall vest as to 1/36 of the shares on May 31, 2018, and on the last day of each successive month thereafter until fully vested, subject to the Reporting Person's continued service with the Issuer through each vesting date.
Documents
Issuer
Paratek Pharmaceuticals, Inc.
CIK 0001178711
Entity typeother
Related Parties
1- filerCIK 0001737142
Filing Metadata
- Form type
- 4
- Filed
- May 1, 8:00 PM ET
- Accepted
- May 2, 4:29 PM ET
- Size
- 8.2 KB